Baxter (BAX) Tops Q1 EPS by 8c, Updates FY Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
Baxter Reports First-Quarter 2019 Results
April 25, 2019 7:15 AM EDTFirst-quarter revenue of $2.6 billion declined 2 percent on a reported basis and increased 2 percent on an operational basis First-quarter GAAP earnings per share (EPS) of $0.66; Adjusted EPS of $0.76 increased 9 percent Company now expects full-year 2019 Adjusted EPS of $3.27 to $3.351
DEERFIELD, Ill.--(BUSINESS WIRE)-- Baxter International Inc. (NYSE: BAX), a leading global medical products company, today reported results for the first quarter of 2019 and increased its full-year 2019 earnings outlook.
We are pleased with the solid start to... More
